Investors often seek stocks that exhibit strong fundamentals complemented by favourable technical indicators. One such technical strategy involves identifying stocks that have gained at least 10% in a quarter, accompanied by trading volumes at least 100% higher than those in the previous quarter.
Importance of rising price with increased volumes
A price increase accompanied by higher trading volumes is a strong indicator of genuine investor interest and market consensus on the stock’s value. High volumes during price rises suggests that movement is backed by substantial participation, reducing the likelihood of price manipulation and indicating a sustainable trend. For investors, such scenarios often present opportunities to enter positions with greater confidence in the continuation of the upward trajectory.
ALSO READBeyond fixed deposits: 5 dividend stocks for steady passive income
A rising price accompanied by increased volume suggests investor interest and the potential for the upward trend to be sustained. Here are three stocks that meet these criteria as of March 27, 2025.
1. Narayana Hrudayalaya (NH)
Narayana Hrudayalaya Limited, headquartered in Bengaluru, India, is a prominent healthcare service provider operating a network of multispecialty and super-specialty hospitals nationwide. The company offers a wide range of medical services, including cardiology, oncology, neurology, and orthopaedics.
Source: TradePoint
In the current quarter, Narayana Hrudayalaya‘s stock price has increased by 31%, with trading volumes up 641% compared to the previous quarter. The quarterly chart indicates a breakout from a symmetrical triangle pattern, signalling a bullish trend. Investors might consider any price dips as potential entry points.
2. GlaxoSmithKline (GSK)
GSK plc, formerly known as GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company headquartered in London. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK focuses on developing, manufacturing, and commercialising general and speciality medicines, as well as vaccines.
Source: TradePoint
This quarter, GlaxoSmithKline’s stock price has risen by 23%, with a 294% increase in trading volumes over the previous quarter. The quarterly chart shows that the stock has retested its 2024 breakout and is trending upwards, presenting a potential opportunity for investors.
3. Aavas Financiers
Aavas Financiers Limited is an Indian housing finance company primarily engaged in providing housing loans to low and middle-income customers in semi-urban and rural areas.
» Read More
